Compare BioNano Genomics Inc (BNGO) vs Dominion Energy Inc (D) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Dominion Energy Inc — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Dominion Energy Inc trades at $68.07 (market cap $59.90B). The key difference: Dominion Energy Inc is far larger — about 4385.1× BioNano Genomics Inc's market cap, and Dominion Energy Inc pays a 3.92% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | D | |
|---|---|---|
Market Cap | $13.66M | $59.90B |
Sector | Health | Utilities |
52-Week High | $4.92 | $71.67 |
52-Week Low | $1.06 | $57.08 |
Enterprise Value | $16.26M | $114.01B |
Dividend Yield | — | 3.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Dominion Energy (D) trades at $67.14, down 0.38% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with Q2 2026 EPS beating estimates at $0.79 versus $0.681 expected, and revenue growth to $16.51B in 2025. Analysts maintain a consensus price target of $70.43, with 34% buy ratings. Recent news highlights data center demand driving performance, though merger speculation with NextEra introduces uncertainty.
Outlook remains cautiously optimistic given earnings beats and dividend consistency, but risks include high debt levels and potential regulatory pressures. The stock offers steady income with a $0.67 quarterly dividend, yet investors should weigh execution risks against growth from energy infrastructure demands.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →
